Clinical trial

Safety Study of a Cytotoxic Lymphocytes (CTL) Based Prostate Cancer Therapy

NCT00891345

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2009-04-01

PhasePHASE1

Study timeline

Study start (unknown)2009-04-01Date precision: month

Registry last updated2012-04-27

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Hormone-refractory Prostate Cancerunresolved

Interventions

ALECSATBIOLOGICAL

Sponsors & collaborators

CytoVac A/Slead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00891345 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.